4 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
Follow AnewPharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) CM082 plus JS001 - Small Cell Lung Cancer | Phase 2 | Unknown | AnewPharma | 30 | 2019-09-18 | 2020-07-09 |
| CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC). CM082 plus JS001 - Non-small Cell Lung Cancer | Phase 2 | Unknown | AnewPharma | 20 | 2019-04-02 | 2020-07-09 |
| Safety and Tolerability of Oral CM082 in Patients With wAMD CM082 - Age-Related Macular Degeneration | Phase 2 | Unknown | AnewPharma | 64 | 2018-11-22 | 2020-01-13 |
| Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. CM082 plus JS001 - Mucosal Melanoma | Phase 2 | Unknown | AnewPharma | 40 | 2018-07-31 | 2019-07-05 |
Carcinoma, Non-Small-Cell Lung (1) · Macular Degeneration (1) · Small Cell Lung Carcinoma (1)
vorolanib (4) · toripalimab (2)
China (4)
Jun Guo, M.D (1) · Yin Shen (1) · Yuankai Shi, MD (1) · Zhao Jun, M.D (1)